30th Mar 2009 17:30
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rules DR 3.1.4R
We hereby inform you that on 27 March 2009, the following individuals, who are all persons discharging managerial responsibilities, were each granted an award under the terms of the AstraZeneca Performance Share Plan over the Company's USD0.25 Ordinary Shares or, in the case of L Tetrault and A Zook, over the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary Share
|
Name of individual |
Target number of shares awarded |
Award price per share |
Normal vesting date |
|
B Angelici |
30,723 |
2280p |
27 March 2012 |
|
A Ekblom |
22,635 |
2280p |
27 March 2012 |
|
J Lundberg |
31,251 |
2280p |
27 March 2012 |
|
J Pott |
23,026 |
2280p |
27 March 2012 |
|
D Smith |
25,000 |
2280p |
27 March 2012 |
|
L Tetrault |
55,444 |
US$33.39 |
27 March 2012 |
|
A Zook |
85,229 |
US$33.39 |
27 March 2012 |
The AstraZeneca Performance Share Plan was approved by shareholders at the Company's AGM in 2005. Awards made under the Plan may not generally vest before the third anniversary of the relevant date of grant nor unless the specified performance target(s) have been met at the end of the three year period which, for this award, is 1 January 2009 to 31 December 2011.
The performance target that applies to this award is the Company's Total Shareholder Return ("TSR") compared to the TSR of a selected peer group of 12 other pharmaceutical companies. The actual number of shares to which a participant may become unconditionally entitled will depend on the extent to which the performance target(s) have been met. A summary of the Plan, including a more detailed explanation of the performance target(s), can be found in the AstraZeneca Annual Report and Form 20-F Information 2008 which is available on the Company's website www.astrazeneca.com.
A C N Kemp
Company Secretary
30 March 2009
Related Shares:
Astrazeneca